Document is current
Any future updates will be listed below
-
Authors
Enomoto, Yasunori https://orcid.org/0000-0003-1920-4268
Katsura, Hiroaki
Fujimura, Takashi
Ogata, Akira
Baba, Saori
Yamaoka, Akira https://orcid.org/0000-0002-8629-5406
Kihara, Miho
Abe, Takaya https://orcid.org/0000-0001-5885-4875
Nishimura, Osamu https://orcid.org/0000-0003-1969-2580
Kadota, Mitsutaka
Hazama, Daisuke
Tanaka, Yugo
Maniwa, Yoshimasa
Nagano, Tatsuya
Morimoto, Mitsuru https://orcid.org/0000-0001-9132-4155
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (19K22630, 20K17238)
G-7 Foundation
Okamoto Foundation for lung fibrosis (2019) Special Postdoctoral Researcher Program of RIKEN
- License Information
-
More Information
Article History
Received: 31 October 2022
Accepted: 31 July 2023
First Online: 31 August 2023
Competing interests
: T.F. is an employee of Otsuka Pharmaceutical Co., Ltd, but there is no financial competing interest in this study. The other authors declare no competing interests.
